Cargando…
Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC-1 cell apoptosis via activating the mROS-HtrA2/Omi pathways
BACKGROUND: Mitochondrial fragmentation drastically regulates the viability of pancreatic cancer through a poorly understood mechanism. The present study used erlotinib to activate mitochondrial fragmentation and then investigated the downstream events that occurred in response to mitochondrial frag...
Autores principales: | Wan, Jun, Cui, Jie, Wang, Lei, Wu, Kunpeng, Hong, Xiaoping, Zou, Yulin, Zhao, Shuang, Ke, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196464/ https://www.ncbi.nlm.nih.gov/pubmed/30377412 http://dx.doi.org/10.1186/s12935-018-0665-1 |
Ejemplares similares
-
Retraction Note to: Excessive mitochondrial fragmentation triggered by erlotinib promotes pancreatic cancer PANC‑1 cell apoptosis via activating the mROS‑HtrA2/Omi pathways
por: Wan, Jun, et al.
Publicado: (2019) -
The function of bacterial HtrA is evolutionally conserved in mammalian HtrA2/Omi
por: Chung, Hea-Jong, et al.
Publicado: (2020) -
Protease-independent control of parthanatos by HtrA2/Omi
por: Weiß, Jonas, et al.
Publicado: (2023) -
Temperature-induced changes of HtrA2(Omi) protease activity and structure
por: Zurawa-Janicka, Dorota, et al.
Publicado: (2012) -
Cloning and Transcriptional Activity of the Mouse Omi/HtrA2 Gene Promoter
por: Liu, Dan, et al.
Publicado: (2016)